Insider Buying: SomnoMed Limited (ASX:SOM) Insider Buys 665,000 Shares of Stock

SomnoMed Limited (ASX:SOM) insider Gaetano (Guy) Russo bought 665,000 shares of the company’s stock in a transaction on Thursday, December 5th. The stock was bought at an average price of A$0.44 ($0.29) per share, for a total transaction of A$294,595.00 ($190,061.29).

SomnoMed Price Performance

The company has a quick ratio of 1.05, a current ratio of 1.76 and a debt-to-equity ratio of 14.93.

SomnoMed Company Profile

SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral appliances for the treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. Its flagship product SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea.